Case Study / 15 Jun 2011

Novartis

Novartis commissioned Trucost to measure its supply chain environmental risk.

Novartis has a diverse healthcare portfolio, including innovative pharmaceuticals, eye care products, generics, consumer health products, and vaccines and diagnostic tools.

Greenhouse gas emissions and other environmental impacts embedded in the supply chains of major organisations generally far exceed the environmental impacts for which they are directly responsible. Understanding supply chain emissions, environmental costs, and the resulting supplier-buyer interaction often offers a significant opportunity to reduce emissions, improve efficiencies, and reduce cost. Novartis commissioned Trucost to provide a comprehensive assessment of the carbon, waste and water supply chain footprint and identified areas of greatest impact.

“By measuring the environmental footprint and cost of our supply chain we are now able to better understand our impacts and embed sustainability in our strategic decision making. This provides us with the opportunity to improve efficiency and reduce environmental impact from the most intensive suppliers as well as helping to mitigate future reputational risk.”

Trucost News / 26 Nov 2019 Trucost launches Physical Risk Analytics to help assess risks and opportunities from climate change

New dataset and analytics enables investors, companies and governments to weigh risk of companies’ assets from physical impacts of climate change

Read news
Publication / 25 Nov 2019 Understanding Climate Risk at the Asset Level: The Interplay of Transition and Physical Risks

How could the interplay between regulatory transitional risks and physical risks impact the performance of companies across sectors and geographies?

Read publication
1 October, 2019
Events Webinar: Incorporating Physical Risk in TCFD Portfolio Climate Reporting

Join Trucost's complimentary webinar to hear expert opinion on how physical risk factors can impact TCFD reporting.

Find out more

VIEW ALL NEWS & INSIGHTS